Trials / Active Not Recruiting
Active Not RecruitingNCT06461338
Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study
Acupuncture for Enhancing the Effect of Immunotherapy in Advanced NSCLC: a Pilot Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Guangzhou University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicentre, randomized controlled trial evaluates the effect and safety of integrating acupuncture with immunotherapeutic sensitization in treating NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four cycles of standard ICIs combined with chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | acupuncture | Acupuncture at Neiguan(PC6), Zhongwan (CV12), Guanyuan (CV 4), Baihui (DU20), Yintang (GV29), combined with electro-acupuncture at Zusanli(ST36), and Sanyinjiao (SP-6). |
| PROCEDURE | Sham acupuncture | Sham acupuncture at Neiguan(PC6), Zhongwan (CV12), Guanyuan (CV 4), Baihui (DU20), Yintang (GV29), combined with sham electro-acupuncture at Zusanli(ST36), and Sanyinjiao (SP-6). |
Timeline
- Start date
- 2024-08-15
- Primary completion
- 2026-07-01
- Completion
- 2026-09-01
- First posted
- 2024-06-17
- Last updated
- 2025-12-17
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06461338. Inclusion in this directory is not an endorsement.